Clinical Trials : Sponsored Trials

This research study is testing a new investigational device called MarrowStim™ PAD Kit. This strategy is designed to improve blood flow in legs with blocked arteries by attempting to treat diseased blood vessels. Because of the location and extent of the blockages in certain individuals, standard treatments such as surgical bypass (insertion of a vein or synthetic graft to redirect blood flow around the blockage) and angioplasty (insertion of a balloon through the artery to open the blockage) will not improve blood flow to the leg, and amputation is the only alternative.

The potential benefits of MarrowStim™ treatment include relief of pain, healing of ischemic ulcers, and limb salvage.

Only those patients meeting the pre-defined approved inclusion/exclusion criteria are eligible for this clinical trial.

For more information visit: www.clinicaltrialspotlight.com/pages/3538 or call 877.788.3972.

DEFINITIVE™ Ca++ Study – www.legpaintrial.com

Study to evaluate the use of the SilverHawk™ Plaque Excision System and the SpiderFX Embolic Protection Device in the endovascular treatment of moderate to severely calcified femoropopliteal artery lesions.

DEFINITIVE™ LE Study

A study designed confirm the value of plaque excision with the SilverHawk™ System.

Study of the investigational drug trans sodium crocetinate (TSC) in patients with Peripheral Arterial Disease (PAD) and leg pain with walking (intermittent claudication).

Click here for more information.